myduke® facilitates access to clinical support and evidence-based pathways for smoking cessation and the management of nicotine dependency in Australia.
In accordance with Australian regulatory frameworks, certain smoking cessation and nicotine dependency therapies are classified as prescription-only medicines.
Accessing these products requires a clinical assessment by a registered medical practitioner to ensure that the chosen treatment is appropriate for your individual health needs.
AUSTRALIAN LAW
Under the Medical Board of Australia guidelines, a registered doctor must conduct a real-time consultation—either via telehealth or face-to-face—to determine suitability for treatment. Prescriptions cannot be issued based solely on the completion of an online questionnaire.
It’s also illegal to purchase said products through anything other than a licensed pharmacy. Tobacconists, retailers and convenience stores cannot sell therapeutic nicotine products in Australia, and any who do are breaking the law.
THERAPEUTIC STANDARDS (TGO 110)
Therapeutic nicotine products supplied for smoking cessation must comply with the Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021. This standard establishes minimum requirements for quality and safety, including child-resistant packaging and prohibited ingredients.
All treatments by our Australian dispensing partners meet the new standard, including:
-
What information is needed on the product’s label.
-
What child-resistant packaging is needed.
-
Limits on the concentrations.
-
Ingredients that are prohibited in these products.
-
Records that the Australian sponsor must keep for the product.
CLINICAL DISPENSING PROCESS
Dispensing therapeutic nicotine is a clinical process, not a standard retail transaction. All products must be dispensed by a licensed Australian pharmacy following a professional consultation with a pharmacist.
The pharmacist is required to verify the patient's identity, discuss the appropriate use of the therapy, and ensure the amount supplied is consistent with the clinical treatment plan.
If it’s your first order, a pharmacist will be in touch to validate your ID over the phone and confirm your access to pharmacy products based on your treatment plan.
UNDERSTANDING THE CLINICAL PATHWAY TO SMOKING CESSATION
A supervised clinical pathway ensures that smoking cessation efforts are supported by healthcare professionals and evidence-based care. This structured approach allows for the monitoring of progress and the management of nicotine dependence using products that meet rigorous Australian standards. By engaging with registered practitioners, individuals receive medical oversight to mitigate risks associated with unregulated alternatives.